Patterson Companies (PDCO)
(Delayed Data from NSDQ)
$23.22 USD
-0.56 (-2.35%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $23.22 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$23.22 USD
-0.56 (-2.35%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $23.22 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth D Momentum C VGM
Zacks News
PDCO or MMSI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PDCO vs. MMSI: Which Stock Is the Better Value Option?
Pick These 5 Value Stocks With Alluring EV/EBITDA Ratios
by Anindya Barman
We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
6 Stocks to Buy Despite Coronavirus-Driven Market Volatility
by Zacks Equity Research
The coronavirus pandemic is spooking investors, making them hunt for safe stocks to invest. Here are six defensive stocks that provide stable dividends.
Is Patterson Companies (PDCO) Stock a Solid Choice Right Now?
by Zacks Equity Research
Patterson Companies (PDCO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why Patterson Companies (PDCO) Could Be a Top Value Stock Pick
by Zacks Equity Research
Patterson Companies (PDCO) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
PDCO or BDX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PDCO vs. BDX: Which Stock Is the Better Value Option?
Earnings Estimates Rising for Patterson Cos. (PDCO): Will It Gain?
by Zacks Equity Research
Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Patterson Companies (PDCO) Catches Eye: Stock Jumps 5.9%
by Zacks Equity Research
Patterson Companies (PDCO) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Patterson Companies (PDCO) Q3 Earnings Top Estimates, Up Y/Y
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal third-quarter results benefit from higher revenues and solid show by Dental as well as Animal Health segments.
Patterson Cos. (PDCO) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 27.03% and 2.75%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?
STERIS' (STE) Growth Picture Impressive Amid Rising Costs
by Zacks Equity Research
STERIS (STE) growing steadily on favorable underlying market trends, along with new product and service offerings.
What's in Store for Patterson Companies' (PDCO) Q3 Earnings?
by Zacks Equity Research
Patterson Companies (PDCO) expects Animal Health sales to have been soft in fiscal Q3.
Abbott's Alliance With Insulet to Fortify Diabetic Care Unit
by Zacks Equity Research
Both Abbott (ABT) and Insulet will use a pay-as-you-go model to enhance customer acceptance.
Integra LifeSciences Grows Organically Amid Supply Issues
by Zacks Equity Research
Integra LifeSciences' (IART) Codman Specialty Surgical segment registers impressive organic growth in Q4.
Integer Holdings Acquires Inomec, Extends Global Foothold
by Zacks Equity Research
Integer Holdings' (ITGR) Inomec buyout is likely to boost R&D pipeline and also strengthen and expand global foothold.
HealthEquity (HQY) Stock Up on Solid Fiscal 2020 Results
by Zacks Equity Research
HealthEquity (HQY) raises fiscal 2020 view for top and bottom line.
Baxter's Latest Acquisition to Boost Advanced Surgery Arm
by Zacks Equity Research
Baxter's (BAX) Advanced Surgery arm boasts of a wide spectrum of products.
Here's Why You Should Hold on to Cerner (CERN) Stock Now
by Zacks Equity Research
Cerner (CERN) is gaining traction from prudent strategic deals and big data based EHR system. However, weak margins remain a woe.
Here's Why You Should Invest in Cardinal Health Stock Now
by Zacks Equity Research
Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment.
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
by Zacks Equity Research
DaVita (DVA) gains from solid results in the fourth quarter of 2019.
Bleak Outlook for Medical Dental Supplies Industry
by Sreyoshi Mukherjee
Despite digital dentistry and AI being dominant market trends, near-term prospects of the Dental industry look dull.
PDCO vs. WST: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PDCO vs. WST: Which Stock Is the Better Value Option?
Has Patterson Companies (PDCO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (PDCO) Outperforming Other Medical Stocks This Year?
Can Value Investors Consider Patterson Companies (PDCO)?
by Zacks Equity Research
Patterson Companies (PDCO) stock may be a good choice for value-oriented investors right now from multiple angles.
Moving Average Crossover Alert: Patterson Companies
by Zacks Equity Research
Patterson Companies, Inc. (PDCO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.